Russell Hirsch, M.D., Ph.D.

Managing Director, Prospect Venture Partners

Russell co-founded Prospect Venture Partners II and III. Prior to establishing Prospect Venture Partners II and III, Dr. Hirsch was a member of the Health Care Technology Group at Mayfield. Russell played a key role in Mayfield’s investment activities in the biotechnology and medical device sectors. Prior to Mayfield, Russell was at the University of California San Francisco, where he was engaged in biomedical research. In addition to serving on Baxano’s board, Russell serves or has served on the Board of Directors of Intuitive Surgical, Hansen Medical, Opus Medical, Orquest, AVEO Pharmaceuticals, Visiogen, DFine, SentreHEART, Portola Pharmaceuticals, and several other privately-held companies.

Russell holds an M.D. and Ph.D. in Biochemistry from the University of California, San Francisco and a B.A. in Chemistry from the University of Chicago.